IL-1α and IL-1ra secretion from epidermal equivalents and the prediction of the irritation potential of mild soap and surfactant-based consumer products

被引:29
作者
Bernhofer, LP
Barkovic, S
Appa, Y
Martin, KM
机构
[1] Johnson & Johnson Consumer Prod Worldwide, Skin Res Ctr, Skillman, NJ 08558 USA
[2] Neutrogena Corp, Los Angeles, CA 90045 USA
关键词
in vitro; irritation; skin equivalent; IL-1; alpha; IL-1ra; consumer products; surfactants; correlation-in vitro clinical; clinical results;
D O I
10.1016/S0887-2333(98)00088-5
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We have previously evaluated the measurement of viability and cytokine release from skin equivalents, for predicting the skin irritation potential of topically applied surfactants and demonstrated that IL-1 alpha and interleukin-1 receptor antagonist (IL-1ra) release from epidermal skin equivalents correlates with skin irritation potential. In this study, the utility of the model was confirmed by the evaluation of cleansing bars and cleansing lotions that exhibited varying degrees of irritation potential as determined by exaggerated arm wash human clinical studies. Epidermal equivalents were exposed to increasing concentrations of the cleansing bars and cleansing liquids and Viability and release of IL-1 alpha and IL-1ra were measured. Loss of viability was used to identify the stronger irritants of the products tested. A linear correlation was demonstrated between IL-1 alpha and IL-1ra secretion and human irritation data, demonstrating that the model can correctly predict the irritation potential of soap and surfactant products. These results show that this in vitro model is useful for rank ordering the irritation potential of mild consumer products and for demonstrating enhanced mildness in products with minor differences. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 20 条
[1]  
BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P398
[2]  
Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P838
[3]   The influence of the response of skin equivalent systems to topically applied consumer products by epithelial-mesenchymal interactions [J].
Bernhofer, LP ;
Seiberg, M ;
Martin, KM .
TOXICOLOGY IN VITRO, 1999, 13 (02) :219-229
[4]   Cytokine mRNA expression in an in vitro human skin model, SKIN2(TM) [J].
Burleson, FG ;
Limardi, LC ;
Sikorski, EE ;
Rheins, LA ;
Donnelly, TA ;
Gerberick, GF .
TOXICOLOGY IN VITRO, 1996, 10 (05) :513-521
[5]  
CANNON CL, 1993, INITIAL CHARACTERIZA
[6]  
Dinarello Charles A., 1997, Seminars in Oncology, V24, P81
[7]  
Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
[8]   INVITRO RECONSTRUCTION OF HUMAN SKIN - THE USE OF SKIN EQUIVALENTS AS POTENTIAL INDICATORS OF CUTANEOUS TOXICITY [J].
DYKES, PJ ;
EDWARDS, MJ ;
ODONOVAN, MR ;
MERRETT, V ;
MORGAN, HE ;
MARKS, R .
TOXICOLOGY IN VITRO, 1991, 5 (01) :1-&
[9]  
Elmets CA, 1996, IN VITRO TOXICOL, V9, P223
[10]   ASSESSMENT OF CUTANEOUS AND OCULAR IRRITANCY - A DECADE OF RESEARCH ON ALTERNATIVES TO ANIMAL EXPERIMENTATION [J].
HERZINGER, T ;
KORTING, HC ;
MAIBACH, HI .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 24 (01) :29-41